![Philip L. Calamia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip L. Calamia
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Philip L. Calamia
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Encorium Group, Inc.
![]() Encorium Group, Inc. Miscellaneous Commercial ServicesCommercial Services Encorium Group, Inc. is a clinical research organization which is engaged in the design and management of complex clinical trials for the pharmaceutical and biotechnology industries. It offers on a global basis broad range of clinical research and development services supporting Phase I through Phase IV clinical trials. The company's services include study protocol design, clinical trials management, global data management services, biostatistics, medical and regulatory affairs, quality assurance and compliance and medical report writing. The Encorium offers therapeutic areas such as vaccines, oncology, CNS/psychiatry, cardiovascular, dermatology, rheumatology, respiratory disorders and renal and urinary disorders. The company was founded on August 1, 1998 and is headquartered in Wayne, Pennsylvania.
11
| Private Company | Miscellaneous Commercial Services | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Philip L. Calamia via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Virogenomics BioDevelopment, Inc.
![]() Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | Biotechnology | Chief Operating Officer | |
Novitas Capital III LP
![]() Novitas Capital III LP Investment ManagersFinance Novitas Capital III LP seeks investment opportunities in companies located in the Mid-Atlantic region with a primary focus on Pennsylvania (US). The fund targets companies operating in the fields of technology and life science. It acts as a lead and co-lead investor for start-up and early stage capital requirements. Its initial investment size ranges from $0.1 to $2 million and invests up to $6 million over the lifetime of a portfolio investment. | Investment Managers | Corporate Officer/Principal | |
AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AGILE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Acelerate, Inc.
![]() Acelerate, Inc. BiotechnologyHealth Technology Acelerate, Inc. provides systems cell biology solutions. It address the problems of efficacy and toxicity with the cellular systems biology approach. The company was founded in 2004 and is headquartered in Pittsburgh, PA. | Biotechnology | Director/Board Member | |
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
iCeutica, Inc.
![]() iCeutica, Inc. Pharmaceuticals: MajorHealth Technology iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Cernostics, Inc.
![]() Cernostics, Inc. Medical SpecialtiesHealth Technology Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA. | Medical Specialties | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin | |
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal | |
University of Cambridge | College/University | Graduate Degree | |
Nextran
![]() Nextran Medical SpecialtiesHealth Technology Part of Baxter International, Inc., Nextran is an American company that develops and commercializes organ transplantation technologies. The company is based in NJ. Nextran was acquired by Baxter Healthcare Corp. from DNX Corp. on September 27, 1995 for $18 million. | Medical Specialties | President | |
Vector Securities LLC
![]() Vector Securities LLC Investment Banks/BrokersFinance Part of Prudential Financial, Inc., Vector Securities LLC is a company that provides investment banking services. The company is based in Deerfield, IL. Vector Securities was acquired by Prudential Securities on June 09, 1999. | Investment Banks/Brokers | Corporate Officer/Principal | |
Orion Pharma Oy
![]() Orion Pharma Oy Pharmaceuticals: MajorHealth Technology Orion Pharma Oy provides contract manufacturing services to the pharmaceutical sector. Its services include sterile, solid forms, liquid forms, semi-solid forms, hormone, and anti-cancer production, primary as well as secondary packaging, and testing. The company is headquartered in Espoo, Finland. | Pharmaceuticals: Major | President | |
The University of Chicago | College/University | Corporate Officer/Principal Director/Board Member | |
Union Partners LLC
![]() Union Partners LLC Financial ConglomeratesFinance Union Partners LLC operates as a private equity and performance acceleration firm. It offers investment acquisition and management, performance acceleration and private equity specialty services. The firm invests in healthcare, automotive suppliers, construction materials, manufacturing, supply chain, industrial and consumer products and specialty chemicals. The company was founded by John D. Andrica and is headquartered in Cleveland, OH. | Financial Conglomerates | Corporate Officer/Principal | |
Temple University (Pennsylvania) | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Providence College | College/University | Undergraduate Degree | |
West Chester University of Pennsylvania | College/University | Undergraduate Degree | |
The Wistar Institute
![]() The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Biotechnology | Director/Board Member | |
The Philadelphia Contributionship
![]() The Philadelphia Contributionship Specialty InsuranceFinance The Philadelphia Contributionship provides urban community insurance services. Its services include homeowners, dwelling fire, flood and umbrella liability insurance. The company was founded by Ben Franklin in 1752 and is headquartered in Philadelphia, PA. | Specialty Insurance | Chairman | |
University of Leiden | College/University | Graduate Degree | |
Lincoln International LLC
![]() Lincoln International LLC Regional BanksFinance Lincoln International LLC provides investment banking services. It specializes in strategic advisory services including sell-side mergers and acquisitions, buy-side mergers and acquisitions, debt advisory, growth equity, special situations, valuations and opinions and pensions advisory services. The firm offers capital raising, mergers and acquisitions support, and other corporate finance services. It provides their clients with industry knowledge and access to a comprehensive range of buyers, sellers, and investors. The company was founded in 1996 by Lawrence J. Lawson and is headquartered in Chicago, IL. | Regional Banks | Corporate Officer/Principal | |
University of Helsinki | College/University | Doctorate Degree Graduate Degree | |
Paavo Nurmi Foundation | Corporate Secretary | ||
Reinvestment Fund, Inc.
![]() Reinvestment Fund, Inc. Financial ConglomeratesFinance Reinvestment Fund, Inc. operates as a financial institution. It creates opportunities for low-income communities. The firm brings together individual investors, banks, government officials, private foundations and faith-based and community organizations to invest in projects that transform communities. It uses analytical and financial tools which allow in bringing grocery stores, affordable housing, schools and health centers to the communities. The company was founded by Jeremy Nowak in 1985 and is headquartered in Philadelphia, PA. | Financial Conglomerates | Director/Board Member | |
Encorium Oy | Director/Board Member | ||
BioNJ, Inc.
![]() BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member | |
SOCIETAL CDMO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Philadelphia College of Osteopathic Medicine | College/University | Doctorate Degree | |
Datex-Ohmeda, Inc.
![]() Datex-Ohmeda, Inc. Industrial ConglomeratesProducer Manufacturing Part of General Electric Co., Datex-Ohmeda, Inc. develops and manufactures medical equipment. The company is based in Madison, WI. | Industrial Conglomerates | Corporate Officer/Principal | |
LZ Therapeutics, Inc.
![]() LZ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LZ Therapeutics, Inc. develops novel differentiated products for the treatment of neurological disorders. It provides therapeutics to improve patient outcomes, including improved symptom control and potential disease modification. The company was founded by Jay S. Schneider in 2005 and is headquartered in Chester, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
LIPOCINE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Penn State Research Foundation
![]() Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
JBS United Animal Health II LLC | Corporate Officer/Principal | ||
Aalto University School of Business | College/University | Masters Business Admin | |
Forendo Pharma Oy
![]() Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
Bellrock Intelligence, Inc.
![]() Bellrock Intelligence, Inc. Information Technology ServicesTechnology Services Bellrock Intelligence, Inc. operates as a healthcare information technology company. The firm offers business information management services, advanced analytics capabilities, and security and integration. The company was founded by Robert P. Rittereiser in 2007 and is headquartered in Wayne, PA. | Information Technology Services | Director/Board Member | |
BAUDAX BIO, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 41 |
Finland | 9 |
Verenigd Koninkrijk | 2 |
Nederland | 2 |
Sectoraal
Health Technology | 20 |
Consumer Services | 11 |
Finance | 10 |
Commercial Services | 6 |
Health Services | 2 |
Operationeel
Director/Board Member | 30 |
Corporate Officer/Principal | 23 |
Director of Finance/CFO | 12 |
President | 11 |
Undergraduate Degree | 8 |
Sterkste connecties
- Beurs
- Insiders
- Philip L. Calamia
- Bedrijfsconnecties